United States Antibody Production Market Insight
Published: 05 June 2026 | Report Format: Electronic (PDF)
The United States Antibody Production Market is expected to experience significant growth at a rate of 8.7% owing to increasing demand for monoclonal antibodies, rising biologics and biosimilars development, growing investments in biotechnology research, and expanding applications in oncology, immunology, and infectious disease therapeutics.
United States Antibody Production Market Insights Forecasts to 2035
- The United States Antibody Production Market Size Was Estimated USD 6.8 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.70% from 2025 to 2035
- The United States Antibody Production Market Size is Expected to rise around USD 15.7 Billion by 2035
Notable Insights for the United States Antibody Production Market
• The product-based segmentation indicates that the Monoclonal Antibodies & Recombinant Antibody Production Systems segment holds a commanding position with almost 58% market share in the United States Antibody Production Market in 2025 due to increasing utilization in targeted therapies, diagnostics, and drug discovery applications.
• The application-based segmentation shows that the Oncology, Immunology & Infectious Disease Research segment dominates with a market share of almost 63% in the United States Antibody Production Market in 2025 as a result of rising demand for precision medicine and biologic therapeutics.
• The worldwide projected revenue of Thermo Fisher Scientific Inc. in fiscal year 2025 would be around $43 billion, owing to strong demand for bioprocessing technologies, laboratory solutions, and biologics manufacturing services.
• It is expected that increasing investments in cell line development, bioprocess optimization, and AI-driven drug discovery would contribute to market growth, where advanced antibody production technologies improve production efficiency by up to 42% and reduce development timelines by up to 31%.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
• Intelligent Market Research Based on AI for Biotechnology & Biopharmaceuticals
Decisions Advisors offers intelligent market research that includes advanced analysis of monoclonal antibodies, recombinant antibody technologies, bioprocessing systems, biologics manufacturing, and AI-driven drug discovery platforms. Our research identifies potential business opportunities, technology adoption trends, competitive positioning, and key strategic developments shaping the United States Antibody Production Market.
• Highly Effective Research Approaches with Accurate Forecast Analysis
The research process utilizes advanced methodologies including primary interviews with biotechnology companies, pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), academic researchers, and healthcare experts, along with extensive secondary research and data triangulation. The study delivers accurate market sizing, CAGR forecasting, investment analysis, and technology outlooks while examining demand for antibody production solutions across oncology, immunology, infectious disease research, diagnostics, and drug development applications in the United States.
• Highly Competitive Environment Analysis
The report provides an in-depth assessment of leading antibody production companies, innovations in biologics manufacturing, AI-enabled antibody engineering technologies, product launch activities, strategic partnerships, and research collaborations. It also evaluates regulatory developments, biotechnology R&D investments, manufacturing expansion strategies, and emerging growth opportunities within the United States Antibody Production Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Antibody Production Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Antibody Production Market
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Lonza Group AG
• Abcam plc
• GenScript Biotech Corporation
• Cell Signaling Technology, Inc.
• Sartorius AG
Recent Developments:
• In February 2026, Lonza Group AG expanded its biologics manufacturing capabilities with advanced antibody production platforms designed for large-scale monoclonal antibody development.
• In September 2025, Thermo Fisher Scientific Inc. introduced next-generation bioprocessing solutions integrating automation and analytics technologies to enhance antibody production efficiency and quality control.
Market Segmentation:
United States Antibody Production Market, By Product Type
• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Antibody Production Reagents & Kits
• Custom Antibody Production Services
United States Antibody Production Market, By Technology
• Hybridoma Technology
• Recombinant DNA Technology
• Phage Display Technology
• Single B-Cell Antibody Discovery
• AI-Based Antibody Engineering Platforms
United States Antibody Production Market, By Application
• Oncology Research & Therapeutics
• Immunology Research
• Infectious Disease Diagnostics
• Drug Discovery & Development
• Academic & Clinical Research
Expert Views:
The United States Antibody Production Market is going to get bigger because people want biologics. This means companies are putting money into making medicines that are tailored to specific people. The United States Antibody Production Market is also getting bigger because antibodies are being used in ways to help people. For example antibodies are being used to fight cancer help people with immune systems and stop infectious diseases. The United States Antibody Production Market is using tools like artificial intelligence to make antibodies machines that can do lots of work by themselves and better ways to grow cells in labs. All these things will help make the United States Antibody Production Market more efficient and support its growth in areas, like cancer research, diagnostics and making medicines. The United States Antibody Production Market will keep getting bigger.
Author: Govind and Krishna By Spherical Insights and Consulting